Profile
Irackly Mtibelishvily worked as a Director at Argos Therapeutics, Inc. from 2016 to 2018.
He graduated from Moscow State Institute of International Relations and the University of Virginia School of Law with graduate degrees.
Former positions of Irackly Mtibelishvily
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Director/Board Member | 29/11/2018 |
Training of Irackly Mtibelishvily
| University of Virginia School of Law | Graduate Degree |
| Moscow State Institute of International Relations | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Irackly Mtibelishvily
